Extended Data Table 1:

Demographical and clinical characteristics of all study participants.

	Elite Controllers (EC)	ART-treated Participants (ART)
Number of participants	64	41
Age in years*	57 (31 – 75)	55 (34 – 73)
Female (%)	18.75%	21.95%
CD4 counts*	908† (450 – 2,282)	726 (316 – 1,649)
Viral loads	Under limit of detection	Under limit of detection
Number of viral load tests*	18 (3 – 91)	32.5 (4 – 73)
HLA-B*27/B*57 (%)	27.34%‡	8.75%
Time since diagnosis (year)*	17 (1 – 34)	17 (5 – 35)
Recorded duration of undetectable viremia (year)*	9 (1 – 24)	9 (2 – 19)

^*,median with range;

^†,P = 0.0006, tested using two-tailed Mann-Whitney U test;

^‡,P = 0.0012, tested using two-sided Fisher’s exact test.